The expression of an active form of ChREBP led to the re-induction of hepatic lipogenesis in a model of deficiency in SREBP-1c and LXR

被引：0
作者：
Poupeau, A. [1 ]
Rayah-Benhamed, F. [1 ]
Dentin, R. [1 ]
Lobaccaro, J. M. [2 ]
Girard, J. [1 ]
Postic, C. [3 ]
机构：
[1] Univ Paris 05, Dept Endocrinol Metab Canc, INSERM, Inst Cochin,Cnrs Umr 8104,U567, Paris, France
[2] Univ Clermont Ferrand, Photochim Mol & Macromol Lab, CNRS, UMR 6547, F-63177 Clermont Ferrand, France
[3] CNRS, INSERM, U567, Umr8104, Paris, France
来源：
DIABETES & METABOLISM | 2010年 / 36卷
关键词：
D O I：
10.1016/S1262-3636(10)70132-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A34 / A35
页数：2
相关论文
共 50 条
  • [31] Betanin effect on PPAR-α and SREBP-1c expression in NMRI mice model of steatohepatitis with fibrosis
    Yahaghi, L.
    Yaghmaei, Parichehreh
    Hayati-Roodbari, N.
    Irani, S.
    Ebrahim-Habibi, A.
    PHYSIOLOGY INTERNATIONAL, 2020, 107 (01) : 67 - 81
  • [32] The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis
    Zhai, Xuguang
    Yan, Kunfeng
    Fan, Jiye
    Niu, Minghui
    Zhou, Qian
    Zhou, Yan
    Chen, Hongshan
    Zhou, Yajun
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (01) : 197 - 212
  • [33] AMPK Directly Phosphorylates SREBP-1c at Ser 372, Suppresses Hepatic De Novo Lipogenesis, and Prevents Hepatic Steatosis in Diet-Induced Insulin Resistant Mice
    Li, Yu
    Mihaylova, Maria
    Zheng, Bin
    Park, Ogyi
    Gao, Bin
    Verbeuren, Tony J.
    Shaw, Reuben J.
    Cohen, Richard A.
    Zang, Mengwei
    DIABETES, 2011, 60 : A92 - A92
  • [34] Di-2-ethylhexyl phthalate disrupts hepatic lipid metabolism in obese mice by activating the LXR/SREBP-1c and PPAR-α signaling pathways
    Liang, Xiaoping
    Liang, Jiehua
    Zhang, Shengqi
    Yan, Haowei
    Luan, Tiangang
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 914
  • [35] Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism
    Zhang, Xiaoyan
    Liu, Jia
    Su, Wen
    Wu, Jing
    Wang, Chunjiong
    Kong, Xiaomu
    Gustafsson, Jan-Ake
    Ding, Jie
    Ma, Xiaosong
    Guan, Youfei
    JOURNAL OF DIABETES, 2014, 6 (03) : 212 - 220
  • [36] Insulin inhibition of hepatic gene expression involves the transcription factor sterol regulatory element binding protein-1c (SREBP-1c).
    Foufelle, F
    Chakravarty, K
    Leahy, P
    Foretz, M
    Hanson, RW
    Ferre, P
    DIABETOLOGIA, 2000, 43 : A45 - A45
  • [37] Safb1, an RBMX-binding protein, is a newly identified activator in the regulation of hepatic SREBP-1c gene expression
    Omura, Yasushi
    Nishio, Yoshihiko
    Takemoto, Tadashi
    Ikeuchi, Chikako
    Sekine, Osamu
    Morino, Katsutaro
    Maeno, Yasuhiro
    Obata, Toshiyuki
    Ugi, Satoshi
    Maegawa, Hiroshi
    Kimura, Hirshi
    Kashiwagi, Atsunori
    DIABETES, 2008, 57 : A537 - A537
  • [38] SREBP-1c mediates the insulin-dependent hepatic glucokinase expression. (vol 279, pg 30823, 2004)
    Kim, SY
    Kim, H
    Kim, TH
    Im, SS
    Park, SK
    Lee, IK
    Kim, KS
    Ahn, YH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (35) : 37210 - 37210
  • [39] Glycerol Kinase Drives Hepatic de novo Lipogenesis and Triglyceride Synthesis in Nonalcoholic Fatty Liver by Activating SREBP-1c Transcription, Upregulating DGAT1/2 Expression, and Promoting Glycerol Metabolism
    Ouyang, Shuyu
    Zhuo, Shu
    Yang, Mengmei
    Zhu, Tengfei
    Yu, Shuting
    Li, Yu
    Ying, Hao
    Le, Yingying
    ADVANCED SCIENCE, 2024, 11 (46)
  • [40] HESA-A Attenuates Hepatic Steatosis in NAFLD Rat Model Through the Suppression of SREBP-1c and NF-kβ
    Efati, M.
    Khorrami, M.
    Jangravi, Z.
    Mahmoudabadi, A. Z.
    Raeiszadeh, M.
    Sarshoori, J. R.
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (03) : 1283 - 1290
12345